Skip to main content
HUMANA INC logo

HUMANA INC — Investor Relations & Filings

Ticker · HUM ISIN · US4448591028 LEI · 529900YLDW34GJAO4J06 US Financial and insurance activities
Open in API
Filings indexed 3,056 across all filing types
Latest filing 2019-10-02 Director's Dealing
Country US United States of America
Listing US HUM

About HUMANA INC

https://www.humana.com/

Humana Inc. is a health and well-being company offering a broad range of health insurance products and healthcare services. The company primarily focuses on providing Medicare plans, including Medicare Advantage and Prescription Drug Plans (Part D), to eligible individuals. Beyond its Medicare offerings, Humana provides other medical and specialty insurance products. The company operates through two main segments: Insurance, which encompasses its health plans, and CenterWell, which delivers healthcare services such as primary care, pharmacy operations, and in-home care. Humana is committed to a personalized and simplified whole-person healthcare approach, aiming to help its members achieve better health outcomes through integrated care and wellness solutions.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2019-10-02 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-24 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-23 English
FORM 8-K DATED SEPTEMBER 23, 2019
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated September 23, 2019, reporting the election of a new director, Karen W. Katz, to the Board of Directors of Humana Inc. It details the expansion of the board, independence determination, compensation, and related press release. The key section is Item 5.02, which pertains to departure or election of directors or officers. There is no financial data or report attached, only an announcement of a board change. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 4153 characters, which is consistent with a typical 8-K announcement of management changes rather than a full report or financial statement.
2019-09-23 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-04 English
FORM 8-K SEPTEMBER 3, 2019
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text includes a Regulation FD Disclosure about reaffirming earnings guidance for FY 2019, with detailed adjusted EPS figures. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a transcript, proxy, or other specific filing. The document is relatively short (4214 characters) and serves as a disclosure of updated financial guidance and investor communication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2019-09-03 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.